Lv61
3030 积分 2024-08-19 加入
Update of the Australian Guideline for the Management of Cancer Pain in Adults
13天前
已完结
Transdermal buprenorphine patch in the management of post-operative pain in orthopaedic patients: a systematic review looking at efficacy, safety, adverse effects and cost–benefit analysis
14天前
已完结
ACR Appropriateness Criteria® Management of Uterine Fibroids: 2023 Update
6个月前
已完结
Chinese guidelines for the rehabilitation treatment of knee osteoarthritis: An CSPMR evidence‐based practice guideline
6个月前
已完结
Neuropathic pain: From actual pharmacological treatments to new therapeutic horizons
6个月前
已完结
Long-Term Survival Outcomes with Intravesical Docetaxel for Recurrent Nonmuscle Invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy
7个月前
已完结
IL-15 Superagonist NAI in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer
7个月前
已完结
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
7个月前
已完结
Sequential Treatment With Bacillus Calmette-Güerin (BCG) and Mitomycin C Administered With Electromotive Drug Administration (EMDA) in Patients With High-Risk Nonmuscle Invasive Bladder Cancer After BCG Failure
7个月前
已完结
European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
7个月前
已完结
皖公网安备34019202002308
